Data is not available at this time.
Healthcare Special Opportunities Fund is a closed-ended balanced mutual fund focused on the medical and healthcare sectors, managed by LDIC Inc. The fund employs a dual strategy of investing in public equity and fixed income within developed markets, targeting mid- and small-cap growth stocks. Its investment approach combines fundamental and quantitative analysis, leveraging both top-down macroeconomic insights and bottom-up stock selection to optimize portfolio performance. Benchmarking against the MSCI World Healthcare Index, the fund emphasizes in-house research to identify high-potential opportunities in a sector known for its resilience and innovation. The healthcare sector's defensive characteristics and long-term growth prospects provide a stable foundation for the fund's strategy. With a niche focus on healthcare, the fund differentiates itself from broader asset managers, catering to investors seeking targeted exposure to this high-growth industry.
In FY 2023, the fund reported revenue of CAD 716,974 and net income of CAD 437,261, reflecting a healthy profit margin. The diluted EPS stood at CAD 0.18, indicating modest but positive earnings per share. Operating cash flow was robust at CAD 1,110,731, with no capital expenditures, suggesting efficient cash management and a focus on liquidity.
The fund's earnings power is supported by its ability to generate consistent net income and strong operating cash flow. With no debt and CAD 347,376 in cash and equivalents, the fund maintains a conservative capital structure, allowing for flexibility in investment decisions. The absence of leverage underscores a disciplined approach to risk management.
The fund's balance sheet is characterized by a debt-free position and solid liquidity, with cash and equivalents covering operational needs. Total assets are primarily composed of equity and fixed-income investments, aligned with its mandate. The financial health appears stable, with no significant liabilities and a focus on preserving capital while seeking growth opportunities.
The fund's growth is tied to the performance of the healthcare sector, which has shown resilience and innovation-driven expansion. A dividend of CAD 0.27074 per share reflects a commitment to returning capital to shareholders, though the yield should be evaluated in the context of the fund's total return strategy. Future growth will depend on sector trends and the fund's ability to identify winning investments.
With a market cap of CAD 19.1 million, the fund is a small player in the asset management space. The lack of beta data suggests low correlation with broader markets, potentially appealing to investors seeking sector-specific exposure. Valuation metrics should be assessed relative to healthcare-focused peers and the fund's historical performance.
The fund's strategic advantage lies in its specialized focus on healthcare, a sector with enduring demand and innovation potential. Its research-driven approach and conservative financial posture position it well for long-term growth. However, its small size may limit scalability. The outlook depends on healthcare sector dynamics and the fund's ability to capitalize on emerging opportunities.
Fund description and financial data sourced from publicly available disclosures and TSX listings.
show cash flow forecast
| Fiscal year | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |